nash semaglutide Metabolic, biochemical, histological, and transcriptomic effects of in the GAN diet-induced and biopsy-confirmed ob/ob mouse model of semaglutide nash results Therapeutic developments

Key Takeaways FDA-approved semaglutide as a game-changer in weight management

A WL between 10 and 17% under ketosis is not associated with increased appetite feelings or AG plasma concentration, despite reduced fasting concentration of total PYY and CCK AUC

Current clinical data extends through 48 to 68 weeks

References MHRA

When the scale stalls but other metrics improve, you know to stay the course rather than panic and change everything at once

Embrace Non-Scale Victories : Improved energy, better sleep, and boosted self-confidence are important markers of progress, reminding you of the deeper reasons why weight management is important